Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Rituximab/Bendamustine Followed by Rituximab/Cytarabine for Untreated Mantle Cell Lymphoma

NCT01661881 is registered in ClinicalTrials.gov with Christine Ryan as lead sponsor.

NCT NCT01661881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01661881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Rituximab/Bendamustine Followed by Rituximab/Cytarabine for Untreated Mantle Cell Lymphoma
Lead sponsor
Christine Ryan
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 16, 2012
Completion date
April 30, 2030
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma